Verrica Pharmaceuticals Inc. (VRCA) Gross margin 2023–2024
Verrica Pharmaceuticals Inc. (VRCA) gross margin by fiscal year — reported gross profit divided by reported revenue.
65.6%FY2024 · since FY2023: 90.2% → 65.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 65.6% | -24.6 pp |
| FY2023 | 90.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VRCA financial trends
VRCA RevenueVRCA Net incomeVRCA Net marginVRCA Gross profitVRCA Operating incomeVRCA Operating marginVRCA Operating cash flowVRCA Free cash flowVRCA Capital expendituresVRCA Return on equityVRCA Stock buybacksVRCA Dividends paidVRCA Total assetsVRCA Total liabilitiesVRCA Shareholders’ equityVRCA overview →